Search research articles
Contact Us
Filters
Showing results (291-300 of 305) with videos related to
Page
of 31
Sort By:
Advances in Radiation Oncology
|
November 24, 2022
Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
Communications Biology
|
March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifier
Nicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 13, 2026
Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trial
Jolie Ringash, Pedro A Torres-Saavedra, Maura L Gillison, et al.
The Lancet. Oncology
|
May 5, 2018
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology
Robert G Bristow, Brian Alexander, Michael Baumann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxx
Christina L Runge, Jessica A Lyness, Maura L Gillison, et al.
Practical Radiation Oncology
|
April 19, 2019
Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients
Hiram A Gay, Roberto Santiago, Betty Gil, et al.
Journal of the National Cancer Institute
|
December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience
Luana G Sousa, James Edward Bates, Payal Anand, et al.
The Lancet. Oncology
|
February 29, 2024
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis
Laila A Gharzai, Emily Morris, Krithika Suresh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2022
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma
Matthew Bootsma, Rana R McKay, Hamid Emamekhoo, et al.
Lancet (London, England)
|
November 20, 2018
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L Gillison, Andy M Trotti, Jonathan Harris, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 305) with videos related to
Sort By:
Page
of 31
Advances in Radiation Oncology
|
November 24, 2022
Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
Communications Biology
|
March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifier
Nicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 13, 2026
Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy with either cisplatin or cetuximab in the NRG/RTOG 1016 randomized controlled trial
Jolie Ringash, Pedro A Torres-Saavedra, Maura L Gillison, et al.
The Lancet. Oncology
|
May 5, 2018
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology
Robert G Bristow, Brian Alexander, Michael Baumann, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxx
Christina L Runge, Jessica A Lyness, Maura L Gillison, et al.
Practical Radiation Oncology
|
April 19, 2019
Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients
Hiram A Gay, Roberto Santiago, Betty Gil, et al.
Journal of the National Cancer Institute
|
December 4, 2025
Cisplatin during radiation for head and neck cancer: insights from NRG Oncology experience
Luana G Sousa, James Edward Bates, Payal Anand, et al.
The Lancet. Oncology
|
February 29, 2024
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis
Laila A Gharzai, Emily Morris, Krithika Suresh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 26, 2022
Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma
Matthew Bootsma, Rana R McKay, Hamid Emamekhoo, et al.
Lancet (London, England)
|
November 20, 2018
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L Gillison, Andy M Trotti, Jonathan Harris, et al.
Page
of 31